Speaking of the "helmet scam", people may have missed that the LUNAR trial was also stat sig for TTF+CI vs CI.
In short, NVCR has a CI combo that will very likely be approved in about a year.
This might bode well for NVCR's GBM program in combo with CIs where they are already more advanced than NWBO. . 2TheTop (Keytruda/P1/rGBM) completed . Keynote B36 (P2/Keytruda/rGBM) is enrolling . Keynote D58 (P3/Keytruda/nGBM) is planned
Also have a combo trial agreement with Roche for Tencentriq in pancreatic
Amazing how BPs and RAs fail to see the scam that you see.